Exane Derivatives’s Infosys INFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,234
Closed -$51.2K 721
2020
Q1
$51.2K Hold
6,234
0.01% 349
2019
Q4
$67.6K Sell
6,234
-1,457
-19% -$14.7K 0.01% 343
2019
Q3
$87.4K Hold
7,691
0.02% 328
2019
Q2
$82.3K Buy
7,691
+2,404
+45% +$25.5K 0.01% 350
2019
Q1
$57.8K Sell
5,287
-2,345
-31% -$24.8K 0.01% 330
2018
Q4
$72.6K Sell
7,632
-11,800
-61% -$113K 0.01% 344
2018
Q3
$198K Buy
19,432
+14,610
+303% +$149K 0.04% 244
2018
Q2
$46.8K Sell
4,822
-3,188
-40% -$28.5K 0.01% 392
2018
Q1
$70.5K Sell
8,010
-6,554
-45% -$58K 0.01% 331
2017
Q4
$118K Buy
14,564
+1,110
+8% +$8.44K 0.02% 278
2017
Q3
$98.1K Buy
13,454
+4,062
+43% +$30.8K 0.02% 265
2017
Q2
$70.5K Sell
9,392
-1,612
-15% -$12.1K 0.02% 296
2017
Q1
$86.9K Buy
+11,004
New +$82K 0.02% 234

Other funds holding INFY

Exane Derivatives's INFY Position: Q2 2020 in Review

Exane Derivatives sold out of Infosys (INFY) in Q2 2020, closing a stake of 6,234 shares — an estimated $51.2K sold.

Exane Derivatives first reported a position in INFY in Q1 2017 and held it in 13 quarters. The position peaked at $198K in Q3 2018. 358 funds tracked by Wall St. Rank hold INFY as of Q2 2020.

  • Exane Derivatives reported no remaining Infosys position as of Q2 2020 after selling out during the quarter.
  • Exane Derivatives sold 6,234 Infosys shares in Q2 2020, an estimated $51.2K.
  • Exane Derivatives first reported a position in Infosys in Q1 2017 and held it in 13 quarters.
  • Exane Derivatives's Infosys position peaked at $198K in Q3 2018.
  • 358 funds tracked by Wall St. Rank held Infosys as of Q2 2020.

Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.